{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T12:56:38Z","timestamp":1789908998688,"version":"4.0.1"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"published-print":{"date-parts":[[2012,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Pompe disease (Glycogen storage disease type II, GSD II, acid alpha-glucosidase deficiency, acid maltase deficiency, OMIM # 232300) is an autosomal-recessive lysosomal storage disorder due to a deficiency of acid alpha-glucosidase (GAA, acid maltase, EC 3.2.1.20, Swiss-Prot P10253). Clinical manifestations are dominated by progressive weakness of skeletal muscle throughout the clinical spectrum. In addition, the classic infantile form is characterised by hypertrophic cardiomyopathy.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>In a cross-sectional single-centre study we clinically assessed 3 patients with classic infantile Pompe disease and 39 patients with non-classic presentations, measured their acid alpha-glucosidase activities and analysed their GAA genes.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Classic infantile patients had nearly absent residual enzyme activities and a typical clinical course with hypertrophic cardiomyopathy until the beginning of therapy. The disease manifestations in non-classic patients were heterogeneous. There was a broad variability in the decline of locomotive and respiratory function. The age of onset ranged from birth to late adulthood and correlated with enzyme activities. Molecular analysis revealed as many as 33 different mutations, 14 of which are novel. All classic infantile patients had two severe mutations. The most common mutation in the non-classic group was c.-32-13\u2009T\u2009&gt;\u2009G. It was associated with a milder course in this subgroup.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>Disease manifestation strongly correlates with the nature of the GAA mutations, while the variable progression in non-classic Pompe disease is likely to be explained by yet unknown modifying factors. This study provides the first comprehensive dataset on the clinical course and the mutational spectrum of Pompe disease in Germany.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/1750-1172-7-35","type":"journal-article","created":{"date-parts":[[2012,6,14]],"date-time":"2012-06-14T10:45:12Z","timestamp":1339670712000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":74,"title":["A cross-sectional single-centre study on the spectrum of Pompe disease, German patients: molecular analysis of the GAA gene, manifestation and genotype-phenotype correlations"],"prefix":"10.1186","volume":"7","author":[{"given":"Andreas","family":"Herzog","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ralf","family":"Hartung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnold J J","family":"Reuser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pia","family":"Hermanns","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heiko","family":"Runz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nesrin","family":"Karabul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seyfullah","family":"G\u00f6kce","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joachim","family":"Pohlenz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph","family":"Kampmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Lampe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Beck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eugen","family":"Mengel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,6,7]]},"reference":[{"key":"398_CR1","volume-title":"Acid alpha-Glucosidase (acid maltase) deficiency. The metabolic & molecular bases of inherited disease","author":"R Hirschhorn","year":"2001","unstructured":"Hirschhorn R, Reuser AJ: Glycogen storage disease type II. Acid alpha-Glucosidase (acid maltase) deficiency. The metabolic & molecular bases of inherited disease. 8th edition. Edited by: Scriver CR, Beaudet AL, Sly WS, Valle D. New York: McGraw - Hill; 2001.http:\/\/www.ommbid.com","edition":"8"},{"key":"398_CR2","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1542\/peds.112.2.332","volume":"112","author":"HMP van den Hout","year":"2003","unstructured":"van den Hout HMP, Hop W, Van Diggelen OP, Smeitink JAM, Smit GPA, Poll-The BT, Bakker HD, Loonen MCB, De Klerk JBC, Reuser AJJ, van der Ploeg AT: The natural course of infantile Pompe's disease: 20 original cases compared with 133 cases from the literature. Pediatrics. 2003, 112: 332-340. 10.1542\/peds.112.2.332.","journal-title":"Pediatrics"},{"key":"398_CR3","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1016\/j.jpeds.2005.11.033","volume":"148","author":"PS Kishnani","year":"2006","unstructured":"Kishnani PS, Hwu W, Mandel H, Nicolino M, Yong F, Corzo D: A retrospective, multinational, multicenter study on the natural history of infantile-onset Pompe disease. J Pediatr. 2006, 148: 671-676. 10.1016\/j.jpeds.2005.11.033.","journal-title":"J Pediatr"},{"key":"398_CR4","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1093\/brain\/awh384","volume":"128","author":"ML Hagemans","year":"2005","unstructured":"Hagemans ML, Winkel LP, van Doorn PA, Hop WJ, Loonen MC, Reuser AJ, van der Ploeg AT: Clinical manifestation and natural course of late-onset Pompe's disease in 54 Dutch patients. Brain. 2005, 128: 671-677. 10.1093\/brain\/awh384.","journal-title":"Brain"},{"key":"398_CR5","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1016\/j.rmed.2008.12.009","volume":"103","author":"U Mellies","year":"2009","unstructured":"Mellies U, Lofaso F: Pompe disease: a neuromuscular disease with respiratory muscle involvement. Respir Med. 2009, 103: 477-484. 10.1016\/j.rmed.2008.12.009.","journal-title":"Respir Med"},{"key":"398_CR6","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1007\/BF02185782","volume":"97","author":"WL Kuo","year":"1996","unstructured":"Kuo WL, Hirschhorn R, Huie ML, Hirschhorn K: Localization and ordering of acid alpha-glucosidase (GAA) and thymidine kinase (TK1) by fluorescence in situ hybridization. Hum Genet. 1996, 97: 404-406. 10.1007\/BF02185782.","journal-title":"Hum Genet"},{"key":"398_CR7","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1042\/bj2720493","volume":"272","author":"LH Hoefsloot","year":"1990","unstructured":"Hoefsloot LH, Hoogeveen-Westerveld M, Reuser AJ, Oostra BA: Characterization of the human lysosomal alpha-glucosidase gene. Biochem J. 1990, 272: 493-497.","journal-title":"Biochem J"},{"key":"398_CR8","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1002\/j.1460-2075.1988.tb02998.x","volume":"7","author":"LH Hoefsloot","year":"1988","unstructured":"Hoefsloot LH, Hoogeveen-Westerveld M, Kroos MA, van Beeumen J, Reuser AJ, Oostra BA: Primary structure and processing of lysosomal alpha-glucosidase; homology with the intestinal sucrase-isomaltase complex. EMBO J. 1988, 7: 1697-1704.","journal-title":"EMBO J"},{"key":"398_CR9","unstructured":"The Pompe disease mutation database. http:\/\/www.pompecenter.nl\/en\/?Molecular_aspects:Mutations, accessed 27 Feb 2010"},{"key":"398_CR10","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1136\/jmg.32.10.836-a","volume":"32","author":"MA Kroos","year":"1995","unstructured":"Kroos MA, van der Kraan M, van Diggelen OP, Kleijer WJ, Reuser AJ, van den Boogaard MJ, Ausems MG, van Ploos Amstel HK, Poenaru L, Nicolino M: Glycogen storage disease type II: frequency of three common mutant alleles and their associated clinical phenotypes studied in 121 patients. J Med Genet. 1995, 32: 836-837.","journal-title":"J Med Genet"},{"key":"398_CR11","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1002\/humu.20374","volume":"27","author":"AL Montalvo","year":"2006","unstructured":"Montalvo AL, Bembi B, Donnarumma M, Filocamo M, Parenti G, Rossi M, Merlini L, Buratti E, de Filippi P, Dardis A, Stroppiano M, Ciana G, Pittis MG: Mutation profile of the GAA gene in 40 Italian patients with late onset glycogen storage disease type II. Hum Mutat. 2006, 27: 999-1006. 10.1002\/humu.20374.","journal-title":"Hum Mutat"},{"key":"398_CR12","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.ymgme.2007.05.011","volume":"92","author":"L Gort","year":"2007","unstructured":"Gort L, Coll MJ, Chabas A: Glycogen storage disease type II in Spanish patients: high frequency of c.1076-1GC mutation. Mol Genet Metab. 2007, 92: 183-187. 10.1016\/j.ymgme.2007.05.011.","journal-title":"Mol Genet Metab"},{"key":"398_CR13","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1212\/WNL.55.8.1122","volume":"55","author":"P Laforet","year":"2000","unstructured":"Laforet P, Nicolino M, Eymard PB, Puech JP, Caillaud C, Poenaru L, Fardeau M: Juvenile and adult-onset acid maltase deficiency in France: genotype-phenotype correlation. Neurology. 2000, 55: 1122-1128. 10.1212\/WNL.55.8.1122.","journal-title":"Neurology"},{"key":"398_CR14","volume-title":"Molecular diagnosis of German patients with late-onset glycogen storage disease type II","author":"PR Joshi","year":"2008","unstructured":"Joshi PR, Gl\u00e4ser D, Schmidt S, Vorgerd M, Winterholler M, Eger K, Zierz S, Deschauer M: Molecular diagnosis of German patients with late-onset glycogen storage disease type II. 2008, 10.1007\/s10545-008-0820-2. accessed 20 Nov 2008"},{"key":"398_CR15","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1093\/hmg\/5.7.995","volume":"5","author":"N Raben","year":"1996","unstructured":"Raben N, Nichols RC, Martiniuk F, Plotz PH: A model of mRNA splicing in adult lysosomal storage disease (glycogenosis type II). Hum Mol Genet. 1996, 5: 995-1000. 10.1093\/hmg\/5.7.995.","journal-title":"Hum Mol Genet"},{"key":"398_CR16","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1002\/humu.10286","volume":"23","author":"MM Hermans","year":"2004","unstructured":"Hermans MM, van Leenen D, Kroos MA, Beesley CE, van der Ploeg AT, Sakuraba H, Wevers R, Kleijer W, Michelakakis H, Kirk EP, Fletcher J, Bosshard N, Basel-Vanagaite L, Besley G, Reuser AJ: Twenty-two novel mutations in the lysosomal alpha-glucosidase gene (GAA) underscore the genotype-phenotype correlation in glycogen storage disease type II. Hum Mutat. 2004, 23: 47-56. 10.1002\/humu.10286.","journal-title":"Hum Mutat"},{"key":"398_CR17","doi-asserted-by":"publisher","first-page":"1689","DOI":"10.1172\/JCI113008","volume":"79","author":"AJ Reuser","year":"1987","unstructured":"Reuser AJ, Kroos M, Willemsen R, Swallow D, Tager JM, Galjaard H: Clinical diversity in glycogenosis type II. Biosynthesis and in situ localization of acid alpha-glucosidase in mutant fibroblasts. J. Clin. Invest. 1987, 79: 1689-1699. 10.1172\/JCI113008.","journal-title":"J. Clin. Invest"},{"key":"398_CR18","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1212\/01.wnl.0000252798.25690.76","volume":"68","author":"MA Kroos","year":"2007","unstructured":"Kroos MA, Pomponio RJ, Hagemans ML, Keulemans JLM, Phipps M, DeRiso M, Palmer RE, Ausems MGEM, van der Beek NAME, van Diggelen OP, Halley DJJ, van der Ploeg AT, Reuser AJJ: Broad spectrum of Pompe disease in patients with the same c.-32-13T-G haplotype. Neurology. 2007, 68: 110-115. 10.1212\/01.wnl.0000252798.25690.76.","journal-title":"Neurology"},{"key":"398_CR19","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1136\/heart.83.6.667","volume":"83","author":"C Kampmann","year":"2000","unstructured":"Kampmann C, Wiethoff CM, Wenzel A, Stolz G, Betancor M, Wippermann CF, Huth RG, Habermehl P, Knuf M, Emschermann T, Stopfkuchen H: Normal values of M mode echocardiographic measurements of more than 2000 healthy infants and children in central Europe. Heart. 2000, 83: 667-672. 10.1136\/heart.83.6.667.","journal-title":"Heart"},{"key":"398_CR20","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1002\/ajmg.c.30153","volume":"145C","author":"RE Falk","year":"2007","unstructured":"Falk RE, Casas KA: Chromosome 2q37 deletion: clinical and molecular aspects. Am J Med Genet Part C Semin Med Genet. 2007, 145C: 357-371. 10.1002\/ajmg.c.30153.","journal-title":"Am J Med Genet Part C Semin Med Genet"},{"key":"398_CR21","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1097\/01.gim.0000217785.19262.9e","volume":"8","author":"RM Jack","year":"2006","unstructured":"Jack RM, Gordon C, Scott CR, Kishnani PS, Bali D: The use of acarbose inhibition in the measurement of acid alpha-glucosidase activity in blood lymphocytes for the diagnosis of Pompe disease. Genet Med. 2006, 8: 307-312. 10.1097\/01.gim.0000217785.19262.9e.","journal-title":"Genet Med"},{"key":"398_CR22","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.ymgme.2005.10.016","volume":"88","author":"T Okumiya","year":"2006","unstructured":"Okumiya T, Keulemans JLM, Kroos MA, van der Beek NME, Boer MA, Takeuchi H, van Diggelen OP, Reuser AJJ: A new diagnostic assay for glycogen storage disease type II in mixed leukocytes. Mol Genet Metab. 2006, 88: 22-28. 10.1016\/j.ymgme.2005.10.016.","journal-title":"Mol Genet Metab"},{"key":"398_CR23","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1006\/bbrc.1997.7811","volume":"241","author":"MM Hermans","year":"1997","unstructured":"Hermans MM, van Leenen D, Kroos MA, Reuser AJ: Mutation detection in glycogen storage-disease type II by RT-PCR and automated sequencing. Biochem Biophys Res Commun. 1997, 241: 414-418. 10.1006\/bbrc.1997.7811.","journal-title":"Biochem Biophys Res Commun"},{"key":"398_CR24","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1002\/(SICI)1098-1004(200001)15:1<7::AID-HUMU4>3.0.CO;2-N","volume":"15","author":"JT den Dunnen","year":"2000","unstructured":"den Dunnen JT, Antonarakis SE: Mutation nomenclature extensions and suggestions to describe complex mutations: a discussion. Hum Mutat. 2000, 15: 7-12. 10.1002\/(SICI)1098-1004(200001)15:1<7::AID-HUMU4>3.0.CO;2-N.","journal-title":"Hum Mutat"},{"key":"398_CR25","volume-title":"SNP\u00b4s","author":"NCBI","year":"2009","unstructured":"NCBI: SNP\u00b4s. 2009, http:\/\/www.ncbi.nlm.nih.gov\/SNP\/snp_ref.cgi?showRare=on&chooseRs=all&locusId=2548&mrna=NM_000152.3&ctg=NT_024871.11&prot=NP_000143.2&orien=forward&refresh=refresh, accessed"},{"key":"398_CR26","doi-asserted-by":"publisher","first-page":"E13","DOI":"10.1002\/humu.20745","volume":"29","author":"M Kroos","year":"2008","unstructured":"Kroos M, Pomponio RJ, van Vliet L, Palmer RE, Phipps M, van der Helm R, Halley D, Reuser A: Update of the Pompe disease mutation database with 107 sequence variants and a format for severity rating. Hum Mutat. 2008, 29: E13-E26. 10.1002\/humu.20745.","journal-title":"Hum Mutat"},{"key":"398_CR27","unstructured":"Broad Institute: HapMap Data Rel 27 PhaseII+III, Feb09, on NCBI B36 assembly, dbSNP b126: chr17:75689950.75708273. http:\/\/www.hapmap.org\/cgi-perl\/gbrowse\/hapmap27_B36\/, accessed 7 May 2009"},{"key":"398_CR28","doi-asserted-by":"publisher","first-page":"e448","DOI":"10.1542\/peds.113.5.e448","volume":"113","author":"JMP van den Hout","year":"2004","unstructured":"van den Hout JMP, Kamphoven JHJ, Winkel LPF, Arts WFM, de Klerk JBC, Loonen MCB, Vulto AG, Cromme-Dijkhuis A, Weisglas-Kuperus N, Hop W, van Hirtum H, van Diggelen OP, Boer M, Kroos MA, van Doorn PA, van der Voort E, Sibbles B, van Corven EJJM, Brakenhoff JPJ, van Hove J, Smeitink JAM, de Jong G, Reuser AJJ, van der Ploeg AT: Long-term intravenous treatment of Pompe disease with recombinant human alpha-glucosidase from milk. Pediatrics. 2004, 113: e448-e457. 10.1542\/peds.113.5.e448.","journal-title":"Pediatrics"},{"key":"398_CR29","doi-asserted-by":"publisher","first-page":"e1116","DOI":"10.1542\/peds.2008-3667","volume":"124","author":"Y Chien","year":"2009","unstructured":"Chien Y, Lee N, Thurberg BL, Chiang S, Zhang XK, Keutzer J, Huang A, Wu M, Huang P, Tsai F, Chen Y, Hwu W: Pompe disease in infants: improving the prognosis by newborn screening and early treatment. Pediatrics. 2009, 124: e1116-e1125. 10.1542\/peds.2008-3667.","journal-title":"Pediatrics"},{"key":"398_CR30","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1203\/PDR.0b013e3181b24e94","volume":"66","author":"PS Kishnani","year":"2009","unstructured":"Kishnani PS, Corzo D, Leslie ND, Gruskin D, van der Ploeg A, Clancy JP, Parini R, Morin G, Beck M, Bauer MS, Jokic M, Tsai C, Tsai BWH, Morgan C, O'meara T, Richards S, Tsao EC, Mandel H: Early Treatment with Alglucosidase Alfa Prolongs Long Term Survival of Infants with Pompe Disease. Pediatr Res. 2009, 66: 329-335. 10.1203\/PDR.0b013e3181b24e94.","journal-title":"Pediatr Res"},{"key":"398_CR31","doi-asserted-by":"publisher","first-page":"1396","DOI":"10.1056\/NEJMoa0909859","volume":"362","author":"AT van der Ploeg","year":"2010","unstructured":"van der Ploeg AT, Clemens PR, Corzo D, Escolar DM, Florence J, Groeneveld GJ, Herson S, Kishnani PS, Laforet P, Lake SL, Lange DJ, Leshner RT, Mayhew JE, Morgan C, Nozaki K, Park DJ, Pestronk A, Rosenbloom B, Skrinar A, van Capelle CI, van der Beek NA, Wasserstein M, Zivkovic SA: A randomized study of alglucosidase alfa in late-onset Pompe's disease. N Engl J Med. 2010, 362: 1396-1406. 10.1056\/NEJMoa0909859.","journal-title":"N Engl J Med"},{"key":"398_CR32","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1093\/brain\/93.3.599","volume":"93","author":"AG Engel","year":"1970","unstructured":"Engel AG: Acid maltase deficiency in adults: studies in four cases of a syndrome which may mimic muscular dystrophy or other myopathies. Brain. 1970, 93: 599-616. 10.1093\/brain\/93.3.599.","journal-title":"Brain"},{"key":"398_CR33","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/j.ymgme.2007.07.006","volume":"92","author":"ME McCready","year":"2007","unstructured":"McCready ME, Carson NL, Chakraborty P, Clarke JT, Callahan JW, Skomorowski MA, Chan AK, Bamforth F, Casey R, Rupar CA, Geraghty MT: Development of a clinical assay for detection of GAA mutations and characterization of the GAA mutation spectrum in a Canadian cohort of individuals with glycogen storage disease, type II. Mol Genet Metab. 2007, 92: 325-335. 10.1016\/j.ymgme.2007.07.006.","journal-title":"Mol Genet Metab"},{"key":"398_CR34","first-page":"85","volume":"36","author":"R Hirschhorn","year":"1999","unstructured":"Hirschhorn R, Huie ML: Frequency of mutations for glycogen storage disease type II in different populations: the delta525T and deltaexon 18 mutations are not generally \"common\" in white populations. J Med Genet. 1999, 36: 85-86.","journal-title":"J Med Genet"},{"key":"398_CR35","doi-asserted-by":"publisher","first-page":"E27","DOI":"10.1002\/humu.20753","volume":"29","author":"MG Pittis","year":"2008","unstructured":"Pittis MG, Donnarumma M, Montalvo AL, Dominissini S, Kroos M, Rosano C, Stroppiano M, Bianco MG, Donati MA, Parenti G, D'Amico A, Ciana G, Di Rocco M, Reuser A, Bembi B, Filocamo M: Molecular and functional characterization of eight novel GAA mutations in Italian infants with Pompe disease. Hum Mutat. 2008, 29: E27-E36. 10.1002\/humu.20753.","journal-title":"Hum Mutat"},{"key":"398_CR36","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1007\/s100480050030","volume":"1","author":"M Vorgerd","year":"1998","unstructured":"Vorgerd M, Burwinkel B, Reichmann H, Malin JP, Kilimann MW: Adult-onset glycogen storage disease type II: phenotypic and allelic heterogeneity in German patients. Neurogenetics. 1998, 1: 205-211. 10.1007\/s100480050030.","journal-title":"Neurogenetics"},{"key":"398_CR37","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.nmd.2006.09.004","volume":"17","author":"RE Palmer","year":"2007","unstructured":"Palmer RE, Amartino HM, Niizawa G, Blanco M, Pomponio RJ, Chamoles NA: Pompe disease (glycogen storage disease type II) in Argentineans: clinical manifestations and identification of 9 novel mutations. Neuromuscul Disord. 2007, 17: 16-22. 10.1016\/j.nmd.2006.09.004.","journal-title":"Neuromuscul Disord"},{"key":"398_CR38","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1007\/s10545-011-9360-2","volume":"35","author":"V Manwaring","year":"2012","unstructured":"Manwaring V, Prunty H, Bainbridge K, Burke D, Finnegan N, Franses R, Lam A, Vellodi A, Heales S: Urine analysis of glucose tetrasaccharide by HPLC; a useful marker for the investigation of patients with Pompe and other glycogen storage diseases. J Inherit Metab Dis. 2012, 35: 311-316. 10.1007\/s10545-011-9360-2.","journal-title":"J Inherit Metab Dis"},{"key":"398_CR39","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1016\/0006-291X(91)91906-S","volume":"179","author":"MM Hermans","year":"1991","unstructured":"Hermans MM, de Graaff E, Kroos MA, Wisselaar HA, Oostra BA, Reuser AJ: Identification of a point mutation in the human lysosomal alpha-glucosidase gene causing infantile glycogenosis type II. Biochem Biophys Res Commun. 1991, 179: 919-926. 10.1016\/0006-291X(91)91906-S.","journal-title":"Biochem Biophys Res Commun"},{"key":"398_CR40","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.cccn.2005.05.025","volume":"361","author":"K Umapathysivam","year":"2005","unstructured":"Umapathysivam K, Hopwood JJ, Meikle PJ: Correlation of acid alpha-glucosidase and glycogen content in skin fibroblasts with age of onset in Pompe disease. Clin Chim Acta. 2005, 361: 191-198. 10.1016\/j.cccn.2005.05.025.","journal-title":"Clin Chim Acta"},{"key":"398_CR41","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1007\/s00401-005-1026-4","volume":"110","author":"MC Sharma","year":"2005","unstructured":"Sharma MC, Schultze C, von Moers A, Stoltenburg-Didinger G, Shin YS, Podskarbi T, Isenhardt K, Tews DS, Goebel HH: Delayed or late-onset type II glycogenosis with globular inclusions. Acta Neuropathol. 2005, 110: 151-157. 10.1007\/s00401-005-1026-4.","journal-title":"Acta Neuropathol"},{"key":"398_CR42","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1016\/j.nmd.2007.06.002","volume":"17","author":"W M\u00fcller-Felber","year":"2007","unstructured":"M\u00fcller-Felber W, Horvath R, Gempel K, Podskarbi T, Shin Y, Pongratz D, Walter MC, Baethmann M, Schlotter-Weigel B, Lochmuller H, Schoser B: Late onset Pompe disease: clinical and neurophysiological spectrum of 38 patients including long-term follow-up in 18 patients. Neuromuscul Disord. 2007, 17: 698-706. 10.1016\/j.nmd.2007.06.002.","journal-title":"Neuromuscul Disord"},{"key":"398_CR43","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1016\/j.cell.2009.02.011","volume":"136","author":"TA Cooper","year":"2009","unstructured":"Cooper TA, Wan L, Dreyfuss G: RNA and disease. Cell. 2009, 136: 777-793. 10.1016\/j.cell.2009.02.011.","journal-title":"Cell"},{"key":"398_CR44","doi-asserted-by":"publisher","first-page":"29760","DOI":"10.1074\/jbc.M204721200","volume":"277","author":"B Yan","year":"2002","unstructured":"Yan B, Raben N, Plotz P: The human acid alpha-glucosidase gene is a novel target of the Notch-1\/Hes-1 signaling pathway. J Biol Chem. 2002, 277: 29760-29764. 10.1074\/jbc.M204721200.","journal-title":"J Biol Chem"},{"key":"398_CR45","doi-asserted-by":"publisher","first-page":"3897","DOI":"10.1093\/hmg\/ddn292","volume":"17","author":"N Raben","year":"2008","unstructured":"Raben N, Hill V, Shea L, Takikita S, Baum R, Mizushima N, Ralston E, Plotz P: Suppression of autophagy in skeletal muscle uncovers the accumulation of ubiquitinated proteins and their potential role in muscle damage in Pompe disease. Hum Mol Genet. 2008, 17: 3897-3908. 10.1093\/hmg\/ddn292.","journal-title":"Hum Mol Genet"},{"key":"398_CR46","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1002\/mus.20665","volume":"35","author":"AE Slonim","year":"2007","unstructured":"Slonim AE, Bulone L, Goldberg T, Minikes J, Slonim E, Galanko J, Martiniuk F: Modification of the natural history of adult-onset acid maltase deficiency by nutrition and exercise therapy. Muscle Nerve. 2007, 35: 70-77. 10.1002\/mus.20665.","journal-title":"Muscle Nerve"},{"key":"398_CR47","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1097\/PHM.0b013e3181951fc5","volume":"88","author":"F Ambrosio","year":"2009","unstructured":"Ambrosio F, Kadi F, Lexell J, Fitzgerald GK, Boninger ML, Huard J: The effect of muscle loading on skeletal muscle regenerative potential: an update of current research findings relating to aging and neuromuscular pathology. Am J Phys Med Rehab \/ Assoc Acad Physiatr. 2009, 88: 145-155.","journal-title":"Am J Phys Med Rehab \/ Assoc Acad Physiatr"},{"key":"398_CR48","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1113\/expphysiol.2006.036525","volume":"92","author":"SDR Harridge","year":"2007","unstructured":"Harridge SDR: Plasticity of human skeletal muscle: gene expression to in vivo function. Exp Physiol. 2007, 92: 783-797. 10.1113\/expphysiol.2006.036525.","journal-title":"Exp Physiol"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1750-1172-7-35.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T20:13:55Z","timestamp":1630527235000},"score":1,"resource":{"primary":{"URL":"https:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/1750-1172-7-35"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,6,7]]},"references-count":48,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["398"],"URL":"https:\/\/doi.org\/10.1186\/1750-1172-7-35","relation":{},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,6,7]]},"assertion":[{"value":"31 January 2012","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 June 2012","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 June 2012","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"35"}}